Neurological Soft Signs in Schizophrenia, a Picture of the Knowledge in the Last Decade: A Scoping Review

• Published in: Healthcare (Basel) Vol. 11; no. 10; p. 1471
• Main Authors: Petrescu, Cristian, Petrescu, Diana M, Marian, Gabriela, Focseneanu, Brindusa E, Iliuta, Floris Petru, Ciobanu, Constantin Alexandru, Papacocea, Serban, Ciobanu, Adela M
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 18-05-2023; MDPI
• Subjects: Alcohol; Antipsychotics; Brain research; Complications and side effects; Diagnosis; Hallucinations; Hypotheses; Magnetic resonance imaging; Motor ability; Neurologic manifestations of general diseases; neurological soft signs; Psychiatric research; Psychosis; Psychotropic drugs; rating scales; Review; Risk factors; Schizophrenia; Teenagers; Romania; rating scales; schizophrenia; neurological soft signs; review
• ISSN: 2227-9032; 2227-9032
• DOI: 10.3390/healthcare11101471

(1) Background: Neurological Soft Signs (NSS) are subtle neurological abnormalities that are more common in schizophrenia patients than in healthy individuals and have been regularly observed in neuroleptic-naive first-episode patients, supporting the hypothesis that they are an intrinsic component of schizophrenia. (2) Methods: a review of articles published in the last ten years (from January 2013 to January 2023) was carried out on articles published in ScienceDirect and PubMed, by following the PRISMA Statement extension for scoping reviews (PRISMA-ScR), which evaluated the impact of NSS in correlation with the symptomatology, neuroleptic treatment, and the cerebral structural changes of patients with schizophrenia. (3) Results: thirty articles were included, among them twelve included MRI structural evaluation and four studies with a longitudinal design. (4) Conclusions: interest in researching NSS has increased in recent years, but questions remain about their origin and relationship to schizophrenia symptoms, thus this study aims to fill in information gaps in the hope that future research will help provide individualized treatment. It is suggested that NSS in schizophrenia might have an inherited genetic relationship pattern, thus being in line with a trait viewpoint. Most of the research revealed that schizophrenia patients had higher NSS scores than healthy controls, however, they were rather similar to their first-degree relatives, thus, also arguing in favor of a trait perspective. The greatest improvement in scores is seen in those with a remitting course, as shown by declining NSS ratings concurrent with symptomatology.